openPR Logo
Press release

Radiofrequency Ablation Devices Market Executive Summary, Business Prospects, and Forecast to 2029

10-16-2023 12:49 PM CET | Health & Medicine

Press release from: MAXIMIZE MARKET RESEARCH PVT. LTD.

Radiofrequency Ablation Devices Market

Radiofrequency Ablation Devices Market

Radiofrequency Ablation Devices Market size is expected to reach USD 8.10 Bn. by year 2029 at a CAGR of 11.8% during the forecast period.

Radiofrequency Ablation Devices Market Report Scope and Research Methodology

Report Scope:

The Global Radiofrequency Ablation Devices Market Report offers comprehensive insights into market values, research methodology, drivers, restraints, and regional insights. It delves into market dynamics, including drivers and challenges, while providing recommendations for future opportunities.

The research is based on extensive research and analysis, incorporating inputs from industry experts, government agencies, and market participants, providing a reliable and accurate assessment of the market dynamics and future trends.

Know More About The Report: https://www.maximizemarketresearch.com/market-report/global-radiofrequency-ablation-devices-market/93579/

What are Radiofrequency Ablation Devices Market Dynamics?

The market's growth is primarily driven by the expanding applications of Radiofrequency Ablation technology. RFA is used in the treatment of various medical conditions, including tumors of the adrenal gland, breast, bone, kidney, liver, lung, pancreatic, and thyroid cancer. It has also found applications in dermatology for treating skin lesions, freckles, acne, and skin tags. These advantages of RFA technology contribute significantly to market growth. The growing healthcare expenditure and preference for minimally invasive surgeries are also driving factors.

The report profiles seventeen key players from different regions, considering market leaders, followers, and new entrants while analyzing the market and estimating its size. It examines regional impacts on cost and the availability of advanced technology, providing recommendations for potential hotspots in the Asia-Pacific (APAC) region.

Radiofrequency Ablation Devices Market Segmentation?

by Product

Disposable
Capital
Reusable Equipment

Product: The disposable segment is expected to register the highest CAGR of 10.8% during the forecast period. This growth is driven by the relatively low toxicity and reduced risk of complications associated with disposable radiofrequency ablation devices. Product launches are also expected to fuel market growth, with innovations like the Medtronic OsteoCool RF Ablation system in Canada, offering flexible and predictable treatment.

by End User

Hospital
Clinics
Ambulatory

Please connect with our representative, who will ensure you to get a report sample here @ : https://www.maximizemarketresearch.com/request-sample/93579

Who are Radiofrequency Ablation Devices Market Key Players?

1. Boston Scientific Corporation
2. Medtronic
3. Stryker
4. Cosman Medical, Inc.
5. St. Jude Medical
6. Smith & Nephew
7. Johnson & Johnson (J&J) Services, LLC
8. AngioDynamics
9. AvanosMedical Inc.
10. Abbott
11. Bard (BD)
12. Hologic
13. Articure
14. Merit medical
15. Accuray, Inc.
16. Kimberly-Clark Corporation
17. Biosense Webster, Inc.

Table of content for the Radiofrequency Ablation Devices Market includes:

Part 01: Executive Summary

Part 02: Scope of the Radiofrequency Ablation Devices Market Report

Part 03: Global Radiofrequency Ablation Devices Market Landscape

Part 04: Global Radiofrequency Ablation Devices Market Sizing

Part 05: Global Radiofrequency Ablation Devices Market Segmentation by Type

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework

Part 10: Drivers and Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

For more Information Click Here @ : https://www.maximizemarketresearch.com/request-sample/93579

Regional Insights:

North America: Expected to hold a significant market share due to high cancer prevalence, technological advancements, strong purchasing power, and government support for quality healthcare. In 2019, around 1,762,450 people were diagnosed with cancer in the US, according to the American Cancer Society.

Asia Pacific (APAC): Anticipated to experience rapid growth, driven by increased awareness of cardiac disease, a growing healthcare industry, and the development of various treatment methods in gynecology and cosmetology. Ongoing technological advances and R&D activities in the region will create potential growth opportunities.

Related Reports:

Autonomous Robot Toys Market : https://www.maximizemarketresearch.com/market-report/autonomous-robot-toys-market/147254/

Global Processed Mango Product Market: https://www.maximizemarketresearch.com/market-report/global-processed-mango-product-market/42767/

global PreEngineered Buildings Market: https://www.maximizemarketresearch.com/market-report/global-pre-engineered-buildings-market/30843/

Global Brominated Flame Retardants Market: https://www.maximizemarketresearch.com/market-report/global-brominated-flame-retardants-market/111271/

Contact Maximize Market Research:

3rd Floor, Navale IT Park, Phase 2

Pune Banglore Highway, Narhe,

Pune, Maharashtra 411041, India

sales@maximizemarketresearch.com

+91 96071 95908, +91 9607365656

About Maximize Market Research:

Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Radiofrequency Ablation Devices Market Executive Summary, Business Prospects, and Forecast to 2029 here

News-ID: 3251013 • Views:

More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.

Ready-to-Drink Beverages Market Size to Reach USD 1,227.81 Billion by 2032
Ready-to-Drink Beverages Market Size to Reach USD 1,227.81 Billion by 2032
Ready-to-Drink Beverages Market is poised for substantial growth over the forecast period, driven by changing consumer lifestyles, rising disposable income, expanding urbanization, and increasing demand for convenient beverage solutions. According to recent industry analysis, the global Ready-to-Drink Beverages Market was valued at USD 766.69 Billion in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 6.22% from 2025 to 2032, reaching nearly USD 1,227.81 Billion
Second hand Product Market Set to Surpass USD 1451.34 Billion by 2032, Expanding at a Robust 13.6% CAGR
Second hand Product Market Set to Surpass USD 1451.34 Billion by 2032, Expanding …
Second hand Product Market was valued at USD 594.45 Billion in 2025 and is projected to grow at a robust CAGR of 13.6% from 2025 to 2032, reaching nearly USD 1451.34 Billion by 2032. The rapid expansion of resale ecosystems, increasing consumer preference for cost-effective purchasing, and rising sustainability awareness are significantly driving the growth of the Second hand Product Market globally. Market Overview The Second hand Product Market is undergoing a
Tungsten Market to Reach USD 10.99 Billion by 2032, Driven by Expanding Aerospace, Automotive, and Industrial Applications
Tungsten Market to Reach USD 10.99 Billion by 2032, Driven by Expanding Aerospac …
The Global Tungsten Market is poised for significant expansion over the coming years, with the market size valued at USD 6.41 Billion in 2025 and projected to grow at a CAGR of 8% from 2025 to 2032, reaching nearly USD 10.99 Billion by 2032. Rising industrial demand, technological advancements in material science, and increasing applications in high-performance sectors are collectively driving this steady growth trajectory. Tungsten, recognized for its exceptional hardness,
System-on-Chip (SoC) Market to Reach USD 391.61 Billion by 2032, Driven by 5G, AI, and IoT Expansion
System-on-Chip (SoC) Market to Reach USD 391.61 Billion by 2032, Driven by 5G, A …
The global System-on-Chip (SoC) Market is poised for significant growth over the forecast period, reflecting the rapid evolution of semiconductor technologies and increasing demand for high-performance, energy-efficient electronic devices. Valued at USD 228.06 Billion in 2025, the market is projected to grow at a CAGR of 8.03% from 2025 to 2032, reaching nearly USD 391.61 Billion by 2032. ♦ Request a Free Sample Copy or View Report Summary:https://www.maximizemarketresearch.com/request-sample/33954/ System-on-Chip (SoC) Market Overview A

All 5 Releases


More Releases for Ablation

Pulsed Field Ablation Market Analysis on Therapeutic Area Product Components and …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Pulsed Field Ablation Market- (By Therapeutic Area (Cardiovascular Disorders, Oncological Disorders, Respiratory Disorders, Dermatological Disorders), By Product Components (Catheter, Generator, By Application Area (Ablation, Ablation and Mapping), By Source of Ablation (Pulsed Field Energy, Pulsed Field and Radiofrequency Energy, Pulsed Field and Cryoablation Energy)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034." According to the
Thyroid Ablation Devices Market
Alarming rise in prevalence of thyroid cancer, advancements in thyroid ablation system, rise in government & private funds for development of healthcare sectors, and increase in number of thyroid nodule cases are expected to notably contribute toward the growth of the global thyroid ablation devices market during the forecast period. Rise in prevalence of thyroid cancer and thyroid nodules, demand for minimally invasive procedures, and technological advancements in ablation devices drive
03-12-2021 | Health & Medicine
Fact.MR
Atrial Fibrillation (AF) Ablation Market by Procedure (Catheter Ablation, Surgic …
Arterial fibrillation is a disease that creates irregular and rapid heart rate. Atrial fibrillation ablation is performed to treat the disease. The upper chambers of the heart beat irregularly and contract randomly at a very fast rate, out of coordination with the lower ventricles of the heart due to which the time decreases for the heart muscle relaxation. This increases the rate of heart failure and heart strokes and reduces
Radiofrequency Ablation Devices Market: Emerging Applications of Radiofrequency …
Radiofrequency ablation is a minimally invasive technique that uses heat and electrical energy to destroy cancer cells and other dysfunctional tissues. Recently, it has been used to treat a wide range of medical conditions. Although it is not a primary treatment of cancer, it is used to treat a spot of tumor causing pain and other medical indications. The technique is also used to treat patients suffering from adrenal gland,
Nerve Ablation Devices Market to Record an Exponential CAGR by 2028(Based on pro …
Nerves are the vital part of the body, responsible for carrying signals from different parts of the body to the brain. The nerves carry electrical signals that act on actions such as pain and other movements of the body. The nerve ablation devices are used to treat patient by minimally invasive procedures, where a microelectrode is inserted inside the patient to heat the nerve tissue. The nerve ablation devices help
Interventional Oncology Solutions Market Ablation Radiofrequency Ablation, Cryo …
Interventional oncology is a field of medical science, which includes treatment and diagnosis of cancer and other problems related to cancer using minimally invasive procedures. Interventional oncology uses various techniques such as Ultrasound, computed tomography, X-ray, and magnetic resonance imaging (MRI) to treat tumors located in various organs of the body. Interventional oncology procedures are usually used to treat metastatic or primary cancer. These procedures can be used to treat